Company Description
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.
The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti.
The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers.
OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
| Country | United States |
| Founded | 2007 |
| IPO Date | Oct 12, 2017 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 247 |
| CEO | David R. Bailey |
Contact Details
Address: 2850 Frontier Drive Warsaw, Indiana 46582 United States | |
| Phone | 574-268-6379 |
| Website | orthopediatrics.com |
Stock Details
| Ticker Symbol | KIDS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001425450 |
| CUSIP Number | 68752L100 |
| ISIN Number | US68752L1008 |
| Employer ID | 26-1761833 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Gregory A. Odle | President of Scoliosis |
| Mark C. Throdahl | Executive Chairman |
| David R. Bailey | President, Chief Executive Officer and Director |
| Fred L. Hite | Chief Financial Officer, Principal Financial and Accounting Officer, Chief Operating Officer and Director |
| Daniel J. Gerritzen | Executive Vice President of Legal, General Counsel and Secretary |
| Kevin L. Unger CHE, MBA/MSHA | President of Enabling Technologies |
| Joseph W. Hauser | President of Trauma and Deformity Correction |
| Joel Batts | Senior Vice President of Clinical and Regulatory Affairs |
| Mark Karshner | Senior Vice President of International Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 19, 2024 | EFFECT | Notice of Effectiveness |
| Apr 8, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 8, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 15, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Mar 11, 2024 | 8-K | Current Report |
| Mar 8, 2024 | 10-K | Annual Report |
| Mar 6, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 31, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |